Peroxiredoxin 2 contributes to the malignant phenotype of glioblastoma cells

Key Points

• The malignant phenotype of glioblastoma cells is significantly influenced by peroxiredoxin 2 levels.
• Increased peroxiredoxin 2 expression correlates with greater tumor growth and aggression in glioblastomas.
• Assessment involved cellular experiments tracking tumor growth and phenotypic changes linked to peroxiredoxin 2.
• Findings highlight the potential of targeting peroxiredoxin 2 in glioblastoma therapies, necessitating further exploration.